|
|
||||||||
The Journal of Immunology, Vol 158, Issue 12 5736-5743, Copyright © 1997 by American Association of Immunologists
ARTICLES |
JJ Perez-Villar, I Melero, F Navarro, M Carretero, T Bellon, M Llano, M Colonna, DE Geraghty and M Lopez-Botet
Immunology Service, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Spain.
Human NK cells bear surface receptors that inhibit their cytolytic activity upon specific recognition of MHC class Ia Ags; little is known about the capacity of class Ib molecules to regulate NK cell function. We have studied the roles of different NK inhibitory receptors in recognition of the class Ib HLA-G. To this end, we analyzed the ability of an HLA-defective tumor cell line (721.221) transfected with the membrane form of HLA-G1, which contains the three external domains, to inhibit the cytolytic activity mediated by a panel of NK clones from several donors. A substantial proportion of peripheral blood NK clones appeared to be significantly inhibited by the HLA-G1-transfected cell line (referred to as .221-G1); nevertheless, no relation was observed between the expression and the function of serologically identifiable Ig-SF receptors (p58/p70) and specific recognition of .221-G1 cells. Moreover, p58 killer cell inhibitory receptor-IgG soluble fusion proteins specifically bound to 721.221 transfectants bearing their corresponding HLA-C ligands, but only a weak reactivity with .221-G1 cells was detectable. By contrast, most NK clones blocked by HLA-G1 expressed the CD94/NKG2-A inhibitory receptor, and moreover, CD94- specific mAbs reconstituted their cytolytic activity comparably to anti- HLA class I mAbs. These data support the idea that the CD94/NKG2 receptor complex is involved in the recognition of cells expressing HLA- G1.
This article has been cited by other articles:
![]() |
H. Wang, B. Grzywacz, D. Sukovich, V. McCullar, Q. Cao, A. B. Lee, B. R. Blazar, D. N. Cornfield, J. S. Miller, and M. R. Verneris The unexpected effect of cyclosporin A on CD56+CD16 and CD56+CD16+ natural killer cell subpopulations Blood, September 1, 2007; 110(5): 1530 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Guleria and M. H. Sayegh Maternal Acceptance of the Fetus: True Human Tolerance J. Immunol., March 15, 2007; 178(6): 3345 - 3351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Chisholm and H. T. Reyburn Recognition of Vaccinia Virus-Infected Cells by Human Natural Killer Cells Depends on Natural Cytotoxicity Receptors J. Virol., March 1, 2006; 80(5): 2225 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gonen-Gross, H. Achdout, T. I. Arnon, R. Gazit, N. Stern, V. Horejsi, D. Goldman-Wohl, S. Yagel, and O. Mandelboim The CD85J/Leukocyte Inhibitory Receptor-1 Distinguishes between Conformed and {beta}2-Microglobulin-Free HLA-G Molecules J. Immunol., October 15, 2005; 175(8): 4866 - 4874. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hunt, M. G. Petroff, R. H. McIntire, and C. Ober HLA-G and immune tolerance in pregnancy FASEB J, May 1, 2005; 19(7): 681 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nuckel, V. Rebmann, J. Durig, U. Duhrsen, and H. Grosse-Wilde HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia Blood, February 15, 2005; 105(4): 1694 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salerno-Goncalves, M. Fernandez-Vina, D. M. Lewinsohn, and M. B. Sztein Identification of a Human HLA-E-Restricted CD8+ T Cell Subset in Volunteers Immunized with Salmonella enterica Serovar Typhi Strain Ty21a Typhoid Vaccine J. Immunol., November 1, 2004; 173(9): 5852 - 5862. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gonen-Gross, H. Achdout, R. Gazit, J. Hanna, S.'a. Mizrahi, G. Markel, D. Goldman-Wohl, S. Yagel, V. Horejsi, O. Levy, et al. Complexes of HLA-G Protein on the Cell Surface Are Important for Leukocyte Ig-Like Receptor-1 Function J. Immunol., August 1, 2003; 171(3): 1343 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Chiang, M. Henson, and I. Stroynowski The Nonclassical Major Histocompatibility Complex Molecule Qa-2 Protects Tumor Cells from NK Cell- and Lymphokine-Activated Killer Cell-Mediated Cytolysis J. Immunol., March 1, 2002; 168(5): 2200 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Fassett, D. M. Davis, M. M. Valter, G. B. Cohen, and J. L. Strominger Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering PNAS, November 20, 2001; (2001) 211563598. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Horuzsko, F. Lenfant, D. H. Munn, and A. L. Mellor Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice Int. Immunol., March 1, 2001; 13(3): 385 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Riteau, C. Menier, I. Khalil-Daher, S. Martinozzi, M. Pla, J. Dausset, E. D. Carosella, and N. Rouas-Freiss HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition Int. Immunol., February 1, 2001; 13(2): 193 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sancho, M. Nieto, M. Llano, J. L. Rodriguez-Fernandez, R. Tejedor, S. Avraham, C. Cabanas, M. Lopez-Botet, and F. Sanchez-Madrid The Tyrosine Kinase PYK-2/RAFTK Regulates Natural Killer (NK) Cell Cytotoxic Response, and Is Translocated and Activated upon Specific Target Cell Recognition and Killing J. Cell Biol., June 12, 2000; 149(6): 1249 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Urvater, N. Otting, J. H. Loehrke, R. Rudersdorf, I. I. Slukvin, M. S. Piekarczyk, T. G. Golos, A. L. Hughes, R. E. Bontrop, and D. I. Watkins Mamu-I: A Novel Primate MHC Class I B-Related Locus with Unusually Low Variability J. Immunol., February 1, 2000; 164(3): 1386 - 1398. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Lutz and Z. B. Kurago Human Leukocyte Antigen Class I Expression on Squamous Cell Carcinoma Cells Regulates Natural Killer Cell Activity Cancer Res., November 1, 1999; 59(22): 5793 - 5799. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-A. Le Gal, B. Riteau, C. Sedlik, I. Khalil-Daher, C. Menier, J. Dausset, J.-G. Guillet, E. D. Carosella, and N. Rouas-Freiss HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes Int. Immunol., August 1, 1999; 11(8): 1351 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Avril, A.-C. Jarousseau, H. Watier, J. Boucraut, P. Le Bouteiller, P. Bardos, and G. Thibault Trophoblast Cell Line Resistance to NK Lysis Mainly Involves an HLA Class I-Independent Mechanism J. Immunol., May 15, 1999; 162(10): 5902 - 5909. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Lanier Natural killer cells fertile with receptors for HLA-G? PNAS, May 11, 1999; 96(10): 5343 - 5345. [Full Text] [PDF] |
||||
![]() |
M. Ponte, C. Cantoni, R. Biassoni, A. Tradori-Cappai, G. Bentivoglio, C. Vitale, S. Bertone, A. Moretta, L. Moretta, and M. C. Mingari Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor PNAS, May 11, 1999; 96(10): 5674 - 5679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajagopalan and E. O. Long A Human Histocompatibility Leukocyte Antigen (HLA)-G-specific Receptor Expressed on All Natural Killer Cells J. Exp. Med., April 5, 1999; 189(7): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S.J. Allan, M. Colonna, L. L. Lanier, T. D. Churakova, J. S. Abrams, S. A. Ellis, A. J. McMichael, and V. M. Braud Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells J. Exp. Med., April 5, 1999; 189(7): 1149 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vitale, R. Castriconi, S. Parolini, D. Pende, M.-L. Hsu, L. Moretta, D. Cosman, and A. Moretta The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+ NK cell clones Int. Immunol., January 1, 1999; 11(1): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Brooks, F. Borrego, P. E. Posch, A. Patamawenu, C. J. Scorzelli, M. Ulbrecht, E. H. Weiss, and J. E. Coligan Specific Recognition of HLA-E, But Not Classical, HLA Class I Molecules by Soluble CD94/NKG2A and NK Cells J. Immunol., January 1, 1999; 162(1): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Ho, J. W. Heusel, M. G. Brown, K. Matsumoto, A. A. Scalzo, and W. M. Yokoyama Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells PNAS, May 26, 1998; 95(11): 6320 - 6325. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Yokoyama HLA class I specificity for natural killer cell receptor CD94/NKG2A: Two for one in more ways than one PNAS, April 28, 1998; 95(9): 4791 - 4794. [Full Text] [PDF] |
||||
![]() |
N. Lee, M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A PNAS, April 28, 1998; 95(9): 5199 - 5204. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Paul, N. Rouas-Freiss, I. Khalil-Daher, P. Moreau, B. Riteau, F. A. Le Gal, M. F. Avril, J. Dausset, J. G. Guillet, and E. D. Carosella HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance PNAS, April 14, 1998; 95(8): 4510 - 4515. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Borrego, M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence-derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell-mediated Lysis J. Exp. Med., March 2, 1998; 187(5): 813 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Mandelboim, L. Pazmany, D. M. Davis, M. Vales-Gomez, H. T. Reyburn, B. Rybalov, and J. L. Strominger Multiple receptors for HLA-G on human natural killer cells PNAS, December 23, 1997; 94(26): 14666 - 14670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Colonna, F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells J. Exp. Med., December 1, 1997; 186(11): 1809 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rouas-Freiss, R. M.-B. Goncalves, C. Menier, J. Dausset, and E. D. Carosella Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis PNAS, October 14, 1997; 94(21): 11520 - 11525. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Fassett, D. M. Davis, M. M. Valter, G. B. Cohen, and J. L. Strominger Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering PNAS, December 4, 2001; 98(25): 14547 - 14552. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |